Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face

NCT05900258 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT05900258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05900258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
Lead sponsor
Medical University of Graz
Phase
Phase 4
Overall status
Completed
Start date
May 11, 2023
Completion date
November 13, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis